Stories about Verlag

Subscribe to topic
Subscribe to Verlag
Language:
english
Content:
All
Date:
All
Yesterday
Last 7 days
July
Reset
19.07.2018 – 11:48

Ringier Axel Springer Media AG

Ringier Axel Springer Media AG acquires 44 percent of No Fluff Jobs and expands classifieds portfolio with the most innovative IT job classifieds in Poland

Warsaw (ots) - Ringier Axel Springer Media AG today acquired 44 percent of the shares in No Fluff Jobs Sp. z o.o., the operator of nofluffjobs.com, a job classifieds platform focusing on the Polish IT job market. The platform will enrich Ringier Axel Springer Media's portfolio and will complement the group ...
17.07.2018 – 14:01

World Innovation Summit for Education (WISE)

The 2018 WISE Awards Winners Announced

Doha, Qatar (ots/PRNewswire) - The WISE Awards recognize six innovative education initiatives from Nigeria, China, USA, Pakistan, South Africa and Canada The World Innovation Summit for Education (WISE), an initiative of Qatar Foundation (QF), announced today the six 2018 WISE Awards winning projects. Each year, the WISE Awards recognize and promote innovative projects from across the world that are ...
29.06.2018 – 01:02

Astellas Pharma Europe Limited

Results From Pivotal Phase 3 PROSPER Trial of XTANDI[TM] (enzalutamide) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Published in New England Journal of Medicine

Tokyo (ots/PRNewswire) - Results show enzalutamide plus androgen deprivation therapy significantly reduced the risk of developing metastases or death by 71 percent compared to placebo plus androgen deprivation therapy[i] FOR EMEA MEDICAL MEDIA ONLY - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji ...
25.06.2018 – 20:00

World Innovation Summit for Education (WISE)

The World Innovation Summit for Education (WISE) to Host Global Education Forum as Part of the United Nations' Global Goals Week, in NYC

New York (ots/PRNewswire) - The World Innovation Summit for Education (WISE), an initiative of Qatar Foundation, will be holding a one-day forum, on September 22nd, as part of the Global Goals Week, during the United Nations General Assembly. The event will take place at the Altman Building, hosting up to 350 ...
21.05.2018 – 11:45

Novo Nordisk A/S

Head-to-Head Trial Shows Refixia® Achieves Greater Total Factor IX Exposure in People With Haemophilia B Than Recombinant Factor IX-Fc Fusion Protein

Glasgow, Scotland (ots/PRNewswire) - Adults with haemophilia B who received a single dose Refixia® (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed a longer half-life for ...